NASDAQ
Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)
♥ 337 Thanks from members
Rocket Pharmaceuticals exhibits a contrasting profile of regulatory milestones, such as KRESLADI accelerated approval and an $180M PRV sale, alongside severe distress in its warrants (RCKTW) nearing penny stock territory with mounting selling pressure.
No chart available for this instrument.